
Howard Golub
Dr. Golub was one of the founding partners and CEO of a number of diagnostic and medical device healthcare companies. He has broad experience in the strategic and execution issues related to bringing medical products to market. In addition, he was also one of the founders and President and CEO of CareStat LLC, a full-service clinical trial consulting company. He now serves as a Principle
in a senior clinical development consulting group (Care-Safe LLC).
In 2014, Dr. Golub served as V.P. of Clinical Research for Walgreens Inc. Starting in 2021, Dr. Golub was asked to be one of the content experts and clinical leads in a NIH/FDA program to help small businesses develop better diagnostics for COVID 19. Dr. Golub has served as Principal Investigator on two large NIH sponsored studies of infant cry analysis (in relation to SIDS and as a predictor of neurodevelopmental outcome). Dr. Golub had an appointment at the Harvard-MIT Division of Health Sciences and Technology as Senior Lecturer, was a Distinguished Fellow at the Center for Biomedical Innovation at MIT, and an adjunct faculty appointment at Boston University School of Public Health in Epidemiology and Biostatistics.